Egerer, M.; Schuch, K.; Schöler, D.; Artusa, F.; Püngel, T.; Holtman, T.M.; Loosen, S.H.; Demir, M.; Wree, A.; Luedde, T.;
et al. Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma. Cancers 2024, 16, 3651.
https://doi.org/10.3390/cancers16213651
AMA Style
Egerer M, Schuch K, Schöler D, Artusa F, Püngel T, Holtman TM, Loosen SH, Demir M, Wree A, Luedde T,
et al. Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma. Cancers. 2024; 16(21):3651.
https://doi.org/10.3390/cancers16213651
Chicago/Turabian Style
Egerer, Mara, Kathrin Schuch, David Schöler, Fabian Artusa, Tobias Püngel, Theresa Maria Holtman, Sven H. Loosen, Münevver Demir, Alexander Wree, Tom Luedde,
and et al. 2024. "Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma" Cancers 16, no. 21: 3651.
https://doi.org/10.3390/cancers16213651
APA Style
Egerer, M., Schuch, K., Schöler, D., Artusa, F., Püngel, T., Holtman, T. M., Loosen, S. H., Demir, M., Wree, A., Luedde, T., Tacke, F., Roderburg, C., & Mohr, R.
(2024). Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma. Cancers, 16(21), 3651.
https://doi.org/10.3390/cancers16213651